Kainos Medicine Statistics

Total Valuation

Kainos Medicine has a market cap or net worth of KRW 40.86 billion.

Market Cap	40.86B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Kainos Medicine has 33.09 million shares outstanding.

Current Share Class	33.09M
Shares Outstanding	33.09M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.49%
Owned by Institutions (%)	n/a
Float	23.32M

Valuation Ratios

The trailing PE ratio is 199.88.

PE Ratio	199.88
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.06
P/TBV Ratio	2.06
P/FCF Ratio	n/a
P/OCF Ratio	240.66
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.20% and return on invested capital (ROIC) is 0.19%.

Return on Equity (ROE)	0.20%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	0.19%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Kainos Medicine has paid 20.82 million in taxes.

Income Tax	20.82M
Effective Tax Rate	34.28%

Stock Price Statistics

The stock price has decreased by -80.92% in the last 52 weeks. The beta is 1.20, so Kainos Medicine's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	-80.92%
50-Day Moving Average	1,195.68
200-Day Moving Average	2,473.62
Relative Strength Index (RSI)	33.50
Average Volume (20 Days)	71,995

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	60.74M
Pretax Income	60.74M
Net Income	39.92M
EBITDA	n/a
EBIT	60.74M
Earnings Per Share (EPS)	6.18

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	19.83B
Book Value Per Share	3,672.38
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	169.79M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Kainos Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,474.97%
Shareholder Yield	n/a
Earnings Yield	0.10%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 24, 2022. It was a reverse split with a ratio of 0.2.

Last Split Date	Jun 24, 2022
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	3